Genotech Corporation (XKON:066830)
1,298.00
-1.00 (-0.08%)
At close: Jul 29, 2025, 3:30 PM KST
Ligand Pharmaceuticals Market Cap
Genotech has a market cap or net worth of 6.70 billion as of August 1, 2025. Its market cap has decreased by -29.56% in one year.
Market Cap
6.70B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1,298.00
Market Cap Chart
Since April 5, 2017, Genotech's market cap has decreased from 30.32B to 6.70B, a decrease of -77.92%. That is a compound annual growth rate of -16.58%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 6.70B | -7.86% |
Dec 30, 2024 | 7.27B | -31.58% |
Dec 28, 2023 | 10.62B | -34.36% |
Dec 29, 2022 | 16.18B | -23.65% |
Dec 30, 2021 | 21.19B | 6.77% |
Dec 30, 2020 | 19.85B | 108.53% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 450.15T |
SK hynix | 178.11T |
LG Energy Solution | 87.28T |
Samsung Biologics | 73.59T |
Hanwha Aerospace | 48.31T |
Hyundai Motor Company | 45.86T |
HD Hyundai Heavy Industries | 42.30T |
Doosan Enerbility | 39.32T |